Platelet retention test Homburg (RTH) and drug monitoring of platelet adhesive properties of von Willebrand factor;Plättchen-retentionstest Homburg drugmonitoring der plättchenadhäsivität des von-Willebrand-faktors

Hamostaseologie

Volumn 24, Issue 3, 2004, Pages 217-220

  Wieding, Jörk Ulrich ^a,b   Kostering H ^a   Peine, S ^a   Wermes, C ^a   Mestres, P ^a   Wenzel, E ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b NONE   (Germany)

Author keywords

Desmopressin; Platelet adhesion; Von Willebrand factor

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; ADRENALIN; ANTITHROMBOCYTIC AGENT; BLOOD CLOTTING FACTOR 8; COLLAGEN; DESMOPRESSIN; RISTOCETIN; VON WILLEBRAND FACTOR;

BINDING SITE; BLOOD CLOTTING PARAMETERS; CONFERENCE PAPER; DIAGNOSTIC VALUE; DRUG MONITORING; HOMBURG PLATELET RETENTION TEST; HUMAN; IN VITRO STUDY; SENSITIVITY ANALYSIS; SHEAR STRESS; THROMBOCYTE ADHESION; THROMBOGENESIS; VON WILLEBRAND DISEASE;

EID: 4344627102     PISSN: 07209355     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1619630     Document Type: Conference Paper

References (12)

1. Budde U, Drewke E, Will K et al. Standardisierte Diagnostik des von-Willebrand-Syndroms. Hämostaseologie 2004; 24: 12-26.
2. de Groot PG. The role of von Willebrand factor in platelet function. Semin Thromb Hemost 2002; 28: 133-8.
3. Hellem AJ. Platelet adhesiveness in von Willebrand's disease. A study with a new modification of the glass bead filter method. Scand J Haematol 1970; 7: 374-82.
4. Kenet G, Lubetsky A, Shenkman B et al. Cone and platelet analyser (CPA): A new test for the prediction of bleeding among thrombocytopenic patients. Br J Haematol 1998; 101: 255-9.
5. Lethagen S, Berntorp E, Nilsson IM. Pharmacokinetics and hemostatic effect of different factor VIII / von Willebrand factor concentrates in von Willebrand's disease type III. Ann Hematol 1992; 65: 253-9.
6. Mannucci PM. Treatment of von Willebrand disease. Thromb Haemost 2001; 86: 149-53.
7. Merrill EW, Salzman EW, Wan S et al. Platelet-compatible hydrophilic segmented polyurethanes from polyethylene glycols and cyclohexane diisocyanate. Trans Am Soc Artif Intern Organs 1982; 28: 482-7.
8. Sakariassen KS, Aarts PA, de Groot PG et al. A perfusion chamber developed to investigate platelet interaction in flowing blood with human vessel wall cells, their extracellular matrix, and purified components. J Lab Clin Med 1983; 102: 522-35.
9. Savage B, Sixma JJ, Ruggeri ZM. Functional self-association of von Willebrand factor during platelet adhesion under flow. Proc Natl Acad Sci 2002; 99: 425-30.
10. Ruggeri ZM. Platelets in atherothrombosis. Nature Med 2002; 8: 1227-34.
11. Ruggeri ZM. Platelet and von Willebrand factor interactions at the vessel wall. Hämostaseologie 2004; 24: 1-11.
12. Wieding JU, Matern J, Köstering H et al. Platelet retention test Homburg (RTH) in monitoring the adhesive properties of von Willebrand factor after its substitution or desmopressin therapy. Semin Thromb Hemost 2005; 31 (in Bearbeitung)